A Pilot Study of Ultra-High Dose Rate (ConformalFLASH®), for Reirradiation of Carcinoma of the Head and Neck

This pilot study is designed to evaluate the feasibility of delivering ultra-high dose-rate conformal proton therapy (ConformalFLASH) in participants requiring re-irradiation for head and neck cancer who are not amenable to surgical resection. ConformalFLASH treatment planning and delivery workflows are comparable to those of conventional Stereotactic Body Radiation Therapy (SBRT), a standard approach for re-irradiation in this population.

Trial Details

NCT ID
NCT07644585
Phase
NA
Sponsor
IBA Proton Therapy, Inc.
Status
RECRUITING
Cancer Type
Head and Neck Cancer
Interventions
  • ConformalFLASH irradiation
Locations (sample)
  • Philadelphia, Pennsylvania, United States|39.95238,-75.16362

Key Eligibility Criteria

  • Patients must sign an informed consent document that indicates they are aware of the investigational nature of the treatment in this protocol as we…
  • Patients ≥ 18 years old
  • Patients ineligible for or decline upfront surgical resection
  • Histologically confirmed diagnosis of carcinoma of the head and neck

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Head and Neck Cancer Trials on Trialify →